As of May 29
| +0.20 / +0.62%|
The 10 analysts offering 12-month price forecasts for Horizon Pharma PLC have a median target of 37.00, with a high estimate of 42.00 and a low estimate of 31.00. The median estimate represents a +14.09% increase from the last price of 32.43.
The current consensus among 10 polled investment analysts is to Buy stock in Horizon Pharma PLC. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.